Primary sclerosing cholangitis associated colitis: Characterization of clinical, histologic features, and their associations with liver transplantation

被引:12
作者
Aranake-Chrisinger, John [1 ]
Dassopoulos, Themistocles [2 ]
Yan, Yan [3 ,4 ]
Nalbantoglu, ILKe [1 ,5 ]
机构
[1] Washington Univ St Louis, Sch Med, Dept Pathol & Immunol, Lauren V Ackerman Lab Surg Pathol, St Louis, MO 63110 USA
[2] Baylor Univ, Baylor Ctr IBD, Med Ctr, Dallas, TX 75246 USA
[3] Washington Univ St Louis, Sch Med, Dept Surg, St Louis, MO 63110 USA
[4] Washington Univ St Louis, Sch Med, Dept Biostat, St Louis, MO 63110 USA
[5] Yale Univ, Dept Anat Pathol, Sch Med, New Haven, CT 06525 USA
关键词
Primary sclerosing cholangitis; Inflammatory bowel disease; Liver transplantation; Inflammation; Pathologic features; Clinical associations; INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; COLORECTAL NEOPLASIA; COLECTOMY; RISK;
D O I
10.3748/wjg.v26.i28.4126
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND Primary sclerosing cholangitis (PSC) associated inflammatory bowel disease (IBD) is a unique form of IBD (PSC-IBD) with distinct clinical and histologic features from ulcerative colitis (UC) and Crohn disease (CD). In patients with PSC and IBD, the severity of the two disease processes may depend on each other. AIM To study the histologic and clinical features of PSC patients with and without IBD. METHODS We assessed specimens from patients with UC (n= 28), CD (n= 10), PSC and UC (PSC-UC;n= 26); PSC and CD (PSC-CD;n= 6); and PSC and no IBD (PSC-no IBD;n= 4) between years 1999-2013. PSC-IBD patients were matched to IBD patients without PSC by age and colitis duration. Clinical data including age, gender, age at IBD and PSC diagnoses, IBD duration, treatment, follow-up, orthotopic liver transplantation (OLT) were noted. RESULTS PSC-UC patients had more isolated right-sided disease (P= 0.03), and less active inflammation in left colon, rectum (P= 0.03 andP= 0.0006), and overall (P= 0.0005) compared to UC. They required less steroids (P= 0.01) and fewer colectomies (P= 0.03) than UC patients. The PSC-CD patients had more ileitis and less rectal involvement compared to PSC-UC and CD. No PSC-CD patients required OLT compared to 38% of PSC-UC (P= 0.1). PSC-IBD (PSC-UC and PSC-CD) patients with OLT had severe disease in the left colon and rectum (P= 0.04). CONCLUSION PSC-UC represents a distinct form of IBD. The different disease phenotype in PSC-IBD patients with OLT may support liver-gut axis interaction, however warrants clinical attention and further research.
引用
收藏
页码:4126 / 4139
页数:14
相关论文
共 30 条
[1]  
ATKINSON AJ, 1964, JAMA-J AM MED ASSOC, V188, P183
[2]   Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease [J].
Boonstra, Kirsten ;
van Erpecum, Karel J. ;
van Nieuwkerk, Karin M. J. ;
Drenth, Joost P. H. ;
Poen, Alexander C. ;
Witteman, Ben J. M. ;
Tuynman, Hans A. R. E. ;
Beuers, Ulrich ;
Ponsioen, Cyriel Y. .
INFLAMMATORY BOWEL DISEASES, 2012, 18 (12) :2270-2276
[3]   Primary sclerosing cholangitis, inflammatory a bowel disease, and colon cancer [J].
Broome, Ulrika ;
Bergquist, Annika .
SEMINARS IN LIVER DISEASE, 2006, 26 (01) :31-41
[4]   Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipients [J].
Buchholz, Bettina M. ;
Lykoudis, Panagis M. ;
Ravikumar, Reena ;
Pollok, Joerg M. ;
Fusai, Giuseppe K. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (28) :3171-3180
[5]   Consensus statement on the pathology of IgG4-related disease [J].
Deshpande, Vikram ;
Zen, Yoh ;
Chan, John K. ;
Yi, Eunhee E. ;
Sato, Yasuharu ;
Yoshino, Tadashi ;
Kloeppel, Guenter ;
Heathcote, J. Godfrey ;
Khosroshahi, Arezou ;
Ferry, Judith A. ;
Aalberse, Rob C. ;
Bloch, Donald B. ;
Brugge, William R. ;
Bateman, Adrian C. ;
Carruthers, Mollie N. ;
Chari, Suresh T. ;
Cheuk, Wah ;
Cornell, Lynn D. ;
Fernandez-Del Castillo, Carlos ;
Forcione, David G. ;
Hamilos, Daniel L. ;
Kamisawa, Terumi ;
Kasashima, Satomi ;
Kawa, Shigeyuki ;
Kawano, Mitsuhiro ;
Lauwers, Gregory Y. ;
Masaki, Yasufumi ;
Nakanuma, Yasuni ;
Notohara, Kenji ;
Okazaki, Kazuich ;
Ryu, Ji Kon ;
Saeki, Takako ;
Sahani, Dushyant V. ;
Smyrk, Thomas C. ;
Stone, James R. ;
Takahira, Masayuki ;
Webster, George J. ;
Yamamoto, Motohisa ;
Zamboni, Giuseppe ;
Umehara, Hisanori ;
Stone, John H. .
MODERN PATHOLOGY, 2012, 25 (09) :1181-1192
[6]   The Gut-Liver Axis in Primary Sclerosing Cholangitis [J].
Eksteen, Bertus .
CLINICS IN LIVER DISEASE, 2016, 20 (01) :1-+
[7]   Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction? [J].
Jayaram, H ;
Satsangi, J ;
Chapman, RWG .
GUT, 2001, 48 (03) :430-434
[8]   Pathologic Features of Ulcerative Colitis in Patients With Primary Sclerosing Cholangitis A Case-control Study [J].
Joo, Mee ;
Abreu-e-Lima, Paula ;
Farraye, Francis ;
Smith, Timothy ;
Swaroop, Prabhakar ;
Gardner, Laura ;
Lauwers, Gregory Y. ;
Odze, Robert Daniel .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2009, 33 (06) :854-862
[9]   Inflammatory bowel disease in patients with primary sclerosing cholangitis: Clinical characterization in liver transplanted and nontransplanted patients [J].
Jorgensen, Kristin Kaasen ;
Grzyb, Krzysztof ;
Lundin, Knut E. A. ;
Clausen, Ole Petter F. ;
Aamodt, Geir ;
Schrumpf, Erik ;
Vatn, Morten H. ;
Boberg, Kirsten Muri .
INFLAMMATORY BOWEL DISEASES, 2012, 18 (03) :536-545
[10]   The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis [J].
Joshi, Deepak ;
Bjarnason, Ingvar ;
Belgaumkar, Ajay ;
O'Grady, John ;
Suddle, Abid ;
Heneghan, Michael A. ;
Aluvihare, Varuna ;
Rela, Mohammed ;
Heaton, Nigel ;
Agarwal, Kosh .
LIVER INTERNATIONAL, 2013, 33 (01) :53-61